Dementia risk after traumatic brain injury vs nonbrain trauma: the role of age and severity.
Raquel C Gardner, James F Burke, Jasmine Nettiksimmons...
https://pubmed.ncbi.nlm.nih.gov/25347255/Actively Recruiting
Led by University of Texas Southwestern Medical Center · Updated on 2026-07-02
130
Participants Needed
3
Research Sites
60 weeks
Total Duration
Cognitive impairment following moderate to severe traumatic brain injury msTBI affects quality of life and increases risk of dementia. This study aims to understand how acute cerebrovascular injury and its recovery within the first year relate to cognitive outcomes at 12 months after msTBI. Researchers will explore cerebrovascular contributions to cognitive decline and provide data to help develop strategies targeting vascular mechanisms to improve cognition and prevent neurodegeneration after msTBI. Participants include 100 adults with a single moderate to severe TBI and 30 orthopedic trauma controls. Cerebrovascular function will be measured during the acute stage within one week post-injury and at 3, 6, and 12 months using techniques like cerebral blood flow ultrasonography, transcranial Doppler, near-infrared spectroscopy, and beat-to-beat blood pressure monitoring. Brain imaging with MRI will assess brain volume and axonal integrity at 3 and 12 months. Throughout the study, participants will undergo cognitive and clinical assessments including the NIH Toolbox Cognitive Battery, Glasgow Outcome Score-Extended, and quality of life measures. Researchers will collect data on brain structure, cognitive performance, and functional outcomes over 12 months. This longitudinal research will improve understanding of cerebrovascular effects on cognition and help guide future treatments to slow neurodegeneration after msTBI.
CONDITIONS
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury
K
Kan Ding, MD
J
Jill Morales, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Texas Southwestern Medical Center
Lead Sponsor
Albert Einstein College of Medicine
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants undergo non-invasive assessments of brain blood flow, oxygenation, and blood pressure within the first week post-injury. Follow-up visits occur at 3, 6, and 12 months for repeated measurements and brain MRI scans to study brain structure and cognitive function.
Visits at baseline, 3, 6, and 12 months post-injury
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Raquel C Gardner, James F Burke, Jasmine Nettiksimmons...
https://pubmed.ncbi.nlm.nih.gov/25347255/Gill E Sviri, Rune Aaslid, Colleen M Douville...
https://pubmed.ncbi.nlm.nih.gov/19392589/David S Tulsky, Noelle E Carlozzi, James Holdnack...
https://pubmed.ncbi.nlm.nih.gov/29265862/Timothy B Meier, Patrick S F Bellgowan, Rashmi Singh...
https://pubmed.ncbi.nlm.nih.gov/25730545/Peter Nordström, Karl Michaëlsson, Yngve Gustafson...
https://pubmed.ncbi.nlm.nih.gov/24812697/David S Tulsky, Pamela A Kisala, David Victorson...
https://pubmed.ncbi.nlm.nih.gov/25931184/Gabrielle F Miller, Lara DePadilla, Likang Xu
https://pubmed.ncbi.nlm.nih.gov/33528230/M S Vavilala, S Muangman, Nuj Tontisirin...
https://pubmed.ncbi.nlm.nih.gov/16943658/Franck Amyot, Kimbra Kenney, Emily Spessert...
https://pubmed.ncbi.nlm.nih.gov/31790877/Juliana Caldas, Danilo Cardim, Philip Edmundson...
https://pubmed.ncbi.nlm.nih.gov/39479003/University of Texas Southwestern Medical Center
Lead Sponsor
Albert Einstein College of Medicine
Collaborating Sponsor